Combination chemotherapy with cyclophosphamide, thalidomide and dexamethasone achieves a high response rate in patients with newly diagnosed, VAD-refractory and relapsed myeloma [abstract 1499] - Williams, CD; Byrne, JL; Sidra, G (Blood, 2004)
et al.